NEWSROUND ESO Cancer Media Centre 1 May 2006 Senza categoria 0 Number 12 Download pdf article Selected press reports compiled by the ESO Cancer Media Centre Download full article HIVLymphomamediamultiple myelomamyelodysplastic syndromeThalidomidetreatment decisions
Impact Factor Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma Impact Factor 1 September 2008 0
Impact Factor 200 mg-m2 melphalan the gold standard for multiple myeloma Impact Factor 1 November 2010 0
